Ensign Group Shares Jump Nearly 10% After Q3 Profit Beat and Raised Guidance
The U.S. skilled nursing operator beat profit estimates and lifted its 2026 outlook, even as revenue fell short of forecasts.
Shares of The Ensign Group rose sharply after the company reported third-quarter 2026 adjusted earnings of $2.03 a share, ahead of the $1.97 Wall Street had expected. The stock climbed 9.92% to $186.32 in recent trading, up from a previous close of $169.50.
The report was not clean. Revenue came in at $1.48 billion, below the $1.51 billion analysts had forecast, a miss of roughly 2%. Investors chose to focus on the profit line and on management's decision to raise full-year guidance to $7.94 to $8.02 per share, up from the earlier range of $7.75 to $7.85.
The underlying growth was solid. Revenue rose 14.5% from a year earlier, and adjusted earnings per share grew 23.8%. Same-store occupancy reached 84.1%, which the company framed as headroom, since mature facilities typically run in the mid-90% range. Management also pointed to skilled mix and clinical quality, saying more than 80% of its skilled nursing operations hold four- or five-star ratings from the Centers for Medicare & Medicaid Services.
Why it matters: skilled nursing and post-acute care depend heavily on referrals, and referrals tend to follow outcomes and quality scores. A strong quality record can support patient volumes and pricing, which is the kind of operational edge that tends to earn a valuation premium. At a trailing price-to-earnings ratio near 29, the market is already paying for growth, so the guidance raise was the element that gave investors reason to act.
Balance-sheet signals were also reassuring. The company reported about $337.6 million in cash as of September 30, lease-adjusted net debt of roughly 2.0 times EBITDA, and more than $1 billion in available liquidity. It also maintains a quarterly dividend of $0.065 per share as part of a long record of annual increases. Management cited acquisitions and expansion in Florida as future growth drivers.
For readers tracking healthcare stocks, the takeaway is that a revenue miss did not outweigh earnings momentum and a higher outlook. The next test will be whether top-line growth catches up with profit growth in coming quarters. The full earnings call transcript is available at Investing.com.